Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
28%

OVERLAP
BY WEIGHT
20

# OF OVERLAPPING
HOLDINGS
BBP
68
HOLDINGS
33%
ALSO IN PBE
PBE
33
HOLDINGS
69%
ALSO IN BBP
SECTOR DRIFT (BBP minus PBE)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in BBP
Weight
in PBE
Overlap
OMEROS CORP 2.8% 2.3% 2.3%
HALOZYME THERAPEUTICS INC 2.0% 2.6% 2.0%
PROTAGONIST THERAPEUTICS, INC. 1.6% 3.0% 1.6%
REGENERON PHARMACEUTICALS 1.6% 4.7% 1.6%
SAREPTA THERAPEUTICS INC 1.5% 2.8% 1.5%
BBP Overweight Relative to PBE
MODERNA, INC. 5.2%
IOVANCE BIOTHERAPEUTICS INC 4.5%
INTREXON CORP 2.3%
ZAI LAB LTD. UNSPONSORED ADR 1.9%
XERIS PHARMACEUTICALS INC 1.9%
BEIGENE LTD. SPONSORED ADR 1.8%
IMMUNITYBIO INC 1.6%
TARSUS PHARMACEUTICALS, INC. 1.6%
NOVAVAX INC 1.5%
LIGAND PHARMACEUTICALS-CL B 1.5%
BBP Underweight Relative to PBE
ROYALTY PHARMA PLC CLASS A -4.8%
VERTEX PHARMACEUTICALS INC -3.5%
BIOGEN IDEC INC -3.5%
ALNYLAM PHARMACEUTICALS INC -3.4%
UNITED THERAPEUTICS CORP -3.4%
AMGEN INC -3.4%
CAREDX, INC. -3.2%
VERACYTE INC -3.2%
BIO-TECHNE CORPORATION -3.2%
REGENERON PHARMACEUTICALS -3.1%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY